PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Prodiance Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Prodiance and Xyntek Automate Spreadsheet Compliance for 21 CFR Part 11 - Prodiance and Xyntek strategic partnership to deliver spreadsheet control solutions to help global pharmaceutical and biotech organizations mitigate enterprise risk and improve compliance with 21 CFR Part 11 mandates
Prodiance and Xyntek Automate Spreadsheet Compliance for 21 CFR Part 11

 

NewswireToday - /newswire/ - San Ramon, CA, United States, 2009/06/15 - Prodiance and Xyntek strategic partnership to deliver spreadsheet control solutions to help global pharmaceutical and biotech organizations mitigate enterprise risk and improve compliance with 21 CFR Part 11 mandates.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Prodiance Corporation, a leading global provider of Governance, Risk and Compliance solutions, and Xyntek, a global leader in Consulting, Design and Build of IT and Automated Systems Solutions, and Compliance, today announced a strategic partnership to deliver spreadsheet control solutions to help global pharmaceutical and biotech organizations mitigate enterprise risk and improve compliance with 21 CFR Part 11 mandates.

The partnership enables Xyntek to provide best-of-breed IT consulting services including installation, training, project management, and advisory to pharmaceutical and biotech organizations deploying the Prodiance Enterprise Spreadsheet Manager system. Under the partnership, the companies will market and deliver the combined solution.

Based in the Philadelphia area, Xyntek is a recognized leader with over 23 years experience in delivering IT consulting services and solutions to help pharmaceutical and biotech organizations automate a variety of key business processes including drug discovery, research and development, pre-clinical and clinical operations, manufacturing, supply chain, and regulatory and GXP compliance.

"Uncontrolled and unmonitored spreadsheets, Access databases and other end-user computing (EUC) applications can expose life sciences organizations to significant non-compliance and operational risks," said Elliot Abreu, vice president at Xyntek. "A sustainable and automated solution to mitigate these risks requires the combination of domain expertise, best practices and value-added services, combined with market leading technology. Xyntek and Prodiance are now providing a combined, best-of-breed solution to address these needs."

"We’re very pleased to add Xyntek as a trusted channel partner," said Dr. Soheil Saadat, president and CEO of Prodiance Corporation. "The combination of their domain expertise and world class IT services will help accelerate the adoption of Prodiance Enterprise Spreadsheet Management technology within pharmaceutical and biotech organizations on a global basis."

For more information on the combined solution and partnership, Prodiance and Xyntek will be hosting an online seminar entitled 21 CFR Part 11 and Spreadsheets – Best Practices for Mitigating Risk and Improving Compliance on Thursday, June 25th, 2009.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Prodiance Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Prodiance and Xyntek Automate Spreadsheet Compliance for 21 CFR Part 11

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Eric Perry - Prodiance.com 
925-543-0054 eric.perry[.]prodiance.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Prodiance Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Prodiance Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)